Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...

Targets for Drug Action: Overview

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

Pharmacokinetic Models: Overview

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Derivation of elephant induced pluripotent stem cells.

Nature methods·2026

Same author

Qishen Yiqi dripping pills alleviate myocardial ischemia-reperfusion-induced fibrotic injury by inhibiting fibroblast activation via the transforming growth factor-beta/Periostin pathway.

Journal of ethnopharmacology·2026

Same author

Identification, reliability, and validity of drug-drug interaction checkers in chronic diseases: A systematic review.

British journal of pharmacology·2026

Same author

Direct protamine activation of human mast cells is MRGPRX2-dependent and is modulated by heparin.

The Journal of pharmacology and experimental therapeutics·2026

Same author

Predicting disease-specific histone modifications and functional effects of non-coding variants by leveraging DNA language models.

Genome biology·2026

Same author

A geometric deep learning framework for genome-wide prediction of enzyme turnover number.

Genome biology·2026

Same journal

Zero-shot reconstruction of mutant spatial transcriptomes.

Patterns (New York, N.Y.)·2026

Same journal

Dendritic nonlinearities mitigate communication costs.

Patterns (New York, N.Y.)·2026

Same journal

Erratum: Agentic AI as a coordination paradigm in digital health and agri-food systems.

Patterns (New York, N.Y.)·2026

Same journal

Spacing effect improves generalization in biological and artificial systems.

Patterns (New York, N.Y.)·2026

Same journal

A multi-modal foundation model for brain disease diagnosis and medical imaging.

Patterns (New York, N.Y.)·2026

Same journal

DuoMod-Net: Logarithmic balancing and geometric refinement for imbalanced semi-supervised medical image segmentation.

Patterns (New York, N.Y.)·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jan 14, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

Large language models for drug discovery and development.

Yizhen Zheng¹, Huan Yee Koh^1,2, Jiaxin Ju³

¹Department of Data Science and AI, Monash University, Melbourne, VIC, Australia.

Patterns (New York, N.Y.)

|October 27, 2025

Summary

This summary is machine-generated.

Large language models (LLMs) are revolutionizing drug discovery and development by enhancing disease mechanism understanding, de novo drug design, and clinical trial optimization. These AI tools offer transformative potential across the entire pharmaceutical pipeline.

Keywords:

drug development drug discovery large language models

More Related Videos

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Related Experiment Videos

Last Updated: Jan 14, 2026

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Augmenting Large Language Models via Vector Embeddings to Improve Domain-Specific Responsiveness

Published on: December 6, 2024

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Area of Science:

Computational Biology
Pharmacology
AI4Science

Background:

Large language models (LLMs) represent a significant paradigm shift in scientific research.
Their application in drug discovery and development is rapidly expanding.
LLMs offer novel methodologies for complex data interpretation and process optimization.

Purpose of the Study:

To review the expanding role of LLMs in drug discovery and development.
To highlight how LLMs can revolutionize various stages of the pharmaceutical pipeline.
To provide insights into the transformative impact of LLMs for researchers and practitioners.

Main Methods:

Review of current literature and applications of LLMs in pharmacology.
Analysis of LLM capabilities in understanding disease mechanisms.
Investigation of LLM utility in de novo drug design and clinical trial optimization.

Main Results:

LLMs can uncover target-disease linkages and interpret complex biomedical data.
These models enhance drug molecule design and predict efficacy and safety profiles.
LLMs facilitate optimization of clinical trial processes.

Conclusions:

LLMs are poised to transform drug discovery and development.
Their integration offers unprecedented opportunities for pharmaceutical innovation.
Further research and adoption are crucial for realizing the full potential of LLMs in medicine.